| Pdl Biopharma Inc (PDLI) | |||
|---|---|---|---|
| 0 (0%) | 04-20 03:19 | ||
| Open: | Pre. Close: | ||
| High: | Low: | ||
| Volume: | 0 | Market Cap: | 0(M) |
| Stock Technical Analysis | |
|---|---|
| Overall: |  |
| Target: | Six months: 3.12 One year: 3.32 |
| Support: | Support1: 2.39 Support2: 1.99 |
| Resistance: | Resistance1: 2.67 Resistance2: 2.84 |
| Pivot: | 2.58  |
| Moving Averages: | MA(5): 2.47 MA(20): 2.57 MA(100): 2.73 MA(250): 2.99 |
| MACD: | MACD(12,26): Signal(12,26,9): 0.03 |
| %K %D: | %K(14,3): 17.78 %D(3): 17.78 |
| RSI: | RSI(14): 43.91 |
| 52-Week: | High: Low: Change(%): -21.3 |
| Average Vol(K): | 3-Month: 230580 10-Days: 441061 |
| Prices Prediction (Update @5:00pm) | ||
|---|---|---|
| If tomorrow: | Open lower | Open higher |
| High: | 2.476 - 2.488 | 2.488 - 2.498 |
| Low: | 2.435 - 2.452 | 2.452 - 2.466 |
| Close: | 2.446 - 2.472 | 2.472 - 2.493 |
| Price, MAs and Bollinger Bands |
|---|
| Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.PDLI has closed above bottom band by 18.5%. Bollinger Bands are 28.4% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
| Company profile |
|---|
| Stock chart |
|---|
 |
| Financial Analysis | |
|---|---|
| Price to Book Value: | Outperform |
| P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. | |
| Price to Earnings: | Underperform |
| PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). | |
| Discounted cash flow: | Outperform |
| DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. | |
| Return on Assets: | Neutral |
| ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. | |
| Return on Equity: | Underperform |
| ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. | |
| Debt to Equity: | Neutral |
| evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. | |
| Stock Basics & Statistics | |
|---|---|
| Exchange: | |
| Sector: | |
| Industry: | |
| Shares Out. (M) | |
| Shares Float (M) | |
| % Held by Insiders | |
| % Held by Institutions | |
| Shares Short (K) | |
| Shares Short Prior Month (K) | |
| Stock Financials | |
|---|---|
| EPS | |
| Book Value (p.s.) | |
| Profit Margin | |
| Operating Margin | |
| Return on Assets (ttm) | |
| Return on Equity (ttm) | |
| Qtrly Rev. Growth | |
| Gross Profit (p.s.) | 0.118 |
| Sales Per Share | 0.243 |
| EBITDA (p.s.) | -0.376 |
| Qtrly Earnings Growth | |
| Operating Cash Flow (M) | |
| Levered Free Cash Flow (M) | |
| Stock Valuation | |
|---|---|
| PE Ratio | |
| PEG Ratio | |
| Price to Book value | |
| Price to Sales | 10.16 |
| Price to Cash Flow | |
| Stock Dividends | |
|---|---|
| Dividend | |
| Dividend Yield | |
| Dividend Growth | |
